The Enterprise Value as of June 2026 (TTM) for Anbio Biotechnology Class A Ordinary Shares (NNNN) is 676.50M

According to Anbio Biotechnology Class A Ordinary Shares’s latest financial reports and current stock price. The company's current Enterprise Value is 676.50M. This represents a change of -14.40% compared to the average of 790.33M of the last 4 quarters.

Anbio Biotechnology Class A Ordinary Shares (NNNN) Historical Enterprise Value (quarterly & annually)

How has NNNN Enterprise Value performed in the past?

The mean historical Enterprise Value of Anbio Biotechnology Class A Ordinary Shares over the last ten years is 752.17M. The current 676.50M Enterprise Value has changed 8.89% with respect to the historical average. Over the past ten years (40 quarters), NNNN's Enterprise Value was at its highest in in the June 2025 quarter at 1.38B. The Enterprise Value was at its lowest in in the December 2022 quarter at -7102271.00.

Anbio Biotechnology Class A Ordinary Shares (NNNN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Anbio Biotechnology Class A Ordinary Shares Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Anbio Biotechnology Class A Ordinary Shares (NNNN) Average Enterprise Value

How has NNNN Enterprise Value performed in the past?

The current Enterprise Value of Anbio Biotechnology Class A Ordinary Shares (NNNN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Anbio Biotechnology Class A Ordinary Shares (NNNN) Enterprise Value vs. Peers

How is NNNN’s Enterprise Value compared to its peers?

Anbio Biotechnology Class A Ordinary Shares’s Enterprise Value is greater than AngioDynamics, Inc. (462.15M), less than Talkspace, Inc. (841.33M), greater than ClearPoint Neuro, Inc. (431.05M), less than Community Health Systems, Inc. (10.48B), less than COMPASS Pathways plc (697.54M), less than Avanos Medical, Inc. (1.24B), less than KalVista Pharmaceuticals, Inc. (1.49B), greater than Gossamer Bio, Inc. (199.90M), greater than Rigel Pharmaceuticals, Inc. (629.10M), greater than SNDL Inc. (450.73M),

Build a custom stock screener for Anbio Biotechnology Class A Ordinary Shares (NNNN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Anbio Biotechnology Class A Ordinary Shares using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Anbio Biotechnology Class A Ordinary Shares (NNNN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Anbio Biotechnology Class A Ordinary Shares or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.